El Paso Texas Oncology

El Paso, Texas 79902

2 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors — Recruiting now
• Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment. — Completed